Drug Pipeline

iGlarLixi (insulin glargine/lixisenatide) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 4
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06671587 iGlarLixi CGM Study in Chinese T2D Individuals After OADs Type 2 Diabetes (T2D) Recruiting
NCT07307235 Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China… Type 2 Diabetes Not Yet Recruiting
NCT06716424 A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2… Type 2 Diabetes Active, Not Recruiting
Sponsors Running iGlarLixi (insulin glargine/lixisenatide) Trials
Sanofi (2) Shanghai Zhongshan Hospital (1)
Disease Areas
Type 2 Diabetes (3) Diabetes (3)
Get alerts when iGlarLixi (insulin glargine/lixisenatide) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free